93 7219 (Topiramate 100 mg)

Pill with imprint 93 7219 is Yellow, Capsule-shape and has been identified as Topiramate 100 mg. It is supplied by Teva Pharmaceuticals USA.

Topiramate is used in the treatment of migraine prevention; bipolar disorder; seizures; seizure prevention; borderline personality disorder (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7219

Topiramate

Imprint:

93 7219

Strength:

100 mg

Color:

Yellow

Size:

14.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Carbonic anhydrase inhibitor anticonvulsants

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Teva Pharmaceuticals USA

Inactive Ingredients:

silicon dioxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
corn starch
titanium dioxide
hypromelloses
polydextrose
ferric oxide yellow
ferrosoferric oxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
68071-0813	Nucare Pharmaceuticals Inc. (repackager)

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer